The healthcare industry in Brazil posted an unprecedented growth over the past few years on the back of government’s active support and enhanced private investments. Brazil, being the 9th largest economy of the world, has lots of opportunities for the growth of its emerging healthcare market.
According to our new research report “Brazil Healthcare Market Analysis”, the Brazilian healthcare industry is expected to sustain its growth pace in near future owing to the burden of diseases and favoring demographic conditions which will create demand for better healthcare facilities. The demand and supply of drugs is an important factor that has spurred the growth of the healthcare industry and has attracted many private players to bid for tenders for the supply of essential drugs to the public healthcare facilities. Moreover, Brazilians have become more health-conscious, leading to an increased usage of more expensive therapies and innovative products. In this regard, we have done an extensive research and analysis of various segments of the Brazil healthcare market. The segments covered in the report include: Hospital Services Industry, Pharmaceutical Industry, Medical Devices Industry and Other emerging market segments.
The baseline for optimistic future outlook of Brazil’s healthcare industry is the increased participation and high investments made by private players into medical infrastructure and supply of pharmaceuticals to the population. In addition, there will be strong demand for primary health care level drugs, such as generics, antibiotics and OTC, in coming years as a number of drugs are due to lose their patents. As a result, the healthcare industry is expected to grow at a CAGR of around 14.5% during 2010-2013. Moreover, clinical trials conducted by private players make Brazil an ideal destination for research. This will draw the attention of world’s leading healthcare providers and make the Brazilian healthcare sector a lucrative market for further investments.
“Brazil Healthcare Market Analysis” provides thoroughly researched information, authentic data and comparable statistics of the Brazilian healthcare industry. The report has examined current market trends, industrial developments and competitive landscape to enable clients understand the market structure and its expected progress in coming years. It gives an insight into the regulatory environment and industry restraints that facilitate clients in devising strategic plans before taking investment decisions to get optimal returns. The report also contains forecast for all segments of the healthcare industry to give a rogue direction in which these segments are likely to move in coming years.
Table of Contents:
1. Analyst View
2. Healthcare Market Overview
3. Market Drivers
3.1 Favorable Demographics
3.2 Epidemiology
3.3 Government Initiatives
3.4 Private Sector Investments
3.5 Research and Developments
4. Industry Performance
4.1 Pharmaceutical Market
4.1.1 Market Overview
4.1.2 Generic Drugs
4.1.3 Import and Export
4.1.4 Prescription and OTC Drugs
4.2 Medical Device Industry
4.3 Hospital Services Industry
5. Emerging Market Trends
5.1 Health Insurance Industry
5.2 Medical Tourism Industry
5.3 Clinical Trials Industry
5.4 Biotechnology
5.5 Healthcare-IT Market
6. Regulatory Environment
7. Industry Restraints
7.1 Tax System
7.2 Substandard Hospitals
8. Competitive Landscape
8.1 Industry Structure
8.2 Key M&As
8.3 Leading Players
8.3.1 Hospital Services
8.3.2 Pharmaceuticals
8.3.3 Medical Devices
List of Figures:
Figure 2-1: Healthcare Market (Billion US$), 2009-2013
Figure 3-1: Share of Population Diagnosed with Hypertension (2006 & 2009)
Figure 3-2: Prevalence of Hypertension in Population Aged 65 Years & Above (2006 & 2009)
Figure 3-3: Share of Population with Obesity (2006-2008)
Figure 4-1: Share of Brazilian Pharmaceutical Market in Latin America (2008)
Figure 4-2: Pharmaceutical Market (Billion BRL), 2006-2009
Figure 4-3: Pharmaceutical Market (Billion Units), 2008 & 2009
Figure 4-4: Share of Domestic and Foreign Capital in Pharmaceutical Retail Market (2009)
Figure 4-5: Global – Pharmaceutical Market Ranking (2009 & 2011)
Figure 4-6: Forecast for Pharmaceutical Market (Billion BRL), 2010-2013
Figure 4-7: Share of Generics & Branded Drugs in Pharmaceutical Market (2009)
Figure 4-8: Generic Drugs Market (Billion US$), 2008 & 2009
Figure 4-9: Generic Drugs Market (Million Units), 2008 & 2009
Figure 4-10: Pharmaceutical Imports (Billion US$), 2007-2009
Figure 4-11: Pharmaceutical Exports (Million US$), 2007-2009
Figure 4-12: Share of OTC & Prescription Drugs in Pharmaceutical Market (2009)
Figure 4-13: Medical Device Market (Billion US$), 2007-2009
Figure 4-14: Medical Device Imports (Billion US$), 2007-2009
Figure 4-15: Medical Device Exports (Million US$), 2007-2009
Figure 4-16: Number of Doctors (‘000), 2009-2012
Figure 4-17: Share of Physicians in Private Sector (March 2009)
Figure 4-18: Forecast for Demand of Doctors (‘000), 2010-2012
Figure 5-1: Health Insurance Premium (Billion BRL), 2007 & 2008
Figure 5-2: Number of Clinical Trials (2000 & 2008)
Figure 7-1: Tax Rate on Medicines in Brazil, Argentina and Germany (%)
Figure 8-1: Number of Players in Generic Drugs Market (2000 & 2009)
List of Tables:
Table 3-1: Demographic Characteristics (2009-2012)
Table 3-2: Breakup of Obese People by Age Group
Table 4-1: Leading Pharmaceutical Companies by Sales (Million US$)
Table 4-2: Leading Drugs By Sales (Million US$)
Table 5-1: Cost of Various Surgical Procedures in Comparison to United States (US$)
For more please visit
http://www.bharatbook.com/detail.asp?id=144467&rt=Brazil-Healthcare-Market-Analysis.html
OR Contact us at
207, Hermes Atrium, Sector 11, CBD Belapur, Navi Mumbai – 400 614, India.
Phone : +91 22 2757 8668 / 2757 9438
Fax : +91 22 2757 9131
E-mail : info@bharatbook.com
Website : www.bharatbook.com